Moderna Inc (MRNA)
Return on assets (ROA)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | -4,714,000 | 8,362,000 | 12,202,000 | -747,000 | -514,000 |
| Total assets | US$ in thousands | 18,426,000 | 25,858,000 | 24,669,000 | 7,337,000 | 1,589,420 |
| ROA | -25.58% | 32.34% | 49.46% | -10.18% | -32.34% |
December 31, 2023 calculation
ROA = Net income ÷ Total assets
= $-4,714,000K ÷ $18,426,000K
= -25.58%
Return on assets (ROA) is a crucial financial ratio that measures a company's efficiency in generating profits from its assets. Moderna Inc's ROA fluctuated significantly over the past five years, as illustrated by the following annual percentages: -25.58% in 2023, 32.34% in 2022, 49.46% in 2021, -10.18% in 2020, and -32.34% in 2019.
The negative ROA values in 2023, 2020, and 2019 indicate that, during these years, Moderna Inc incurred net losses relative to its assets. The highest ROA was achieved in 2021, where the company generated a return of 49.46% on its assets. This substantial profitability suggests efficient utilization of assets to generate profits during that year.
Overall, the fluctuating ROA values of Moderna Inc suggest variability in its ability to generate returns from its assets over the years. Investors and stakeholders may need to closely monitor the company's asset management strategies and performance to assess its financial health and sustainability.
Peer comparison
Dec 31, 2023